DK0850235T3 - Derivater af quinolin-2(1H)-on som serotoninantagonister - Google Patents

Derivater af quinolin-2(1H)-on som serotoninantagonister

Info

Publication number: DK0850235T3
Authority: DK; Denmark
Prior art keywords: quinoline; derivatives; serotonin antagonists; serotonin; antagonists
Prior art date: 1995-09-15

Application number

DK96931112T

Other languages

Danish (da)

English (en)

Inventor

Michel Aletru

Cort Gary Mc

Christian Hoornaert

Genevieve Dellac

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-15

Filing date

1996-09-12

Publication date

2000-05-29

1995-09-15 Priority claimed from FR9510815A external-priority patent/FR2738822B1/fr

1995-09-21 Priority claimed from FR9511083A external-priority patent/FR2739100B1/fr

1996-09-12 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2000-05-29 Application granted granted Critical

2000-05-29 Publication of DK0850235T3 publication Critical patent/DK0850235T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK96931112T 1995-09-15 1996-09-12 Derivater af quinolin-2(1H)-on som serotoninantagonister DK0850235T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9510815A FR2738822B1 (fr)	1995-09-15	1995-09-15	Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR9511083A FR2739100B1 (fr)	1995-09-21	1995-09-21	Derives de 4-(omega-(4-(4-fluorobenzoyl)piperidin-1-yl)- alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
PCT/FR1996/001401 WO1997010238A1 (fr)	1995-09-15	1996-09-12	Derives de quinolein-2(1h)-one comme antagonistes de la serotonine

Publications (1)

Publication Number	Publication Date
DK0850235T3 true DK0850235T3 (da)	2000-05-29

Family

ID=26232206

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96931112T DK0850235T3 (da)	1995-09-15	1996-09-12	Derivater af quinolin-2(1H)-on som serotoninantagonister

Country Status (30)

Country	Link
US (1)	US5958924A (bg)
EP (1)	EP0850235B1 (bg)
JP (1)	JP3335362B2 (bg)
KR (1)	KR100422850B1 (bg)
CN (1)	CN1094490C (bg)
AR (1)	AR003996A1 (bg)
AT (1)	ATE187172T1 (bg)
AU (1)	AU715879B2 (bg)
BG (1)	BG63779B1 (bg)
BR (1)	BR9610579A (bg)
CA (1)	CA2228038C (bg)
CO (1)	CO4750663A1 (bg)
CZ (1)	CZ288149B6 (bg)
DE (1)	DE69605430T2 (bg)
DK (1)	DK0850235T3 (bg)
EE (1)	EE04116B1 (bg)
ES (1)	ES2142089T3 (bg)
GR (1)	GR3032618T3 (bg)
HK (1)	HK1014868A1 (bg)
HU (1)	HU222745B1 (bg)
IL (1)	IL123600A (bg)
NO (1)	NO323841B1 (bg)
NZ (1)	NZ318436A (bg)
PL (1)	PL184808B1 (bg)
RU (1)	RU2167874C2 (bg)
SI (1)	SI0850235T1 (bg)
SK (1)	SK282222B6 (bg)
TR (1)	TR199800464T1 (bg)
UA (1)	UA44332C2 (bg)
WO (1)	WO1997010238A1 (bg)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997010238A1 (fr) *	1995-09-15	1997-03-20	Synthelabo	Derives de quinolein-2(1h)-one comme antagonistes de la serotonine
FR2761071B1 (fr) *	1997-03-20	1999-12-03	Synthelabo	Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2761067B1 (fr) *	1997-03-20	1999-04-23	Synthelabo	Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) *	1999-08-27	2002-03-29	Adir	Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUP0204496A3 (en) *	2000-01-20	2004-07-28	Eisai Co Ltd	Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same
FR2812548B1 (fr) *	2000-08-01	2002-09-20	Sanofi Synthelabo	Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
GB0420722D0 (en) *	2004-09-17	2004-10-20	Addex Pharmaceuticals Sa	Novel allosteric modulators
TWI320783B (en)	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
FR2909670B1 (fr) *	2006-12-12	2010-07-30	Sanofi Aventis	Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
CN103342695B (zh)	2007-09-14	2015-04-22	杨森制药有限公司	1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
AU2008297876B2 (en)	2007-09-14	2011-07-07	Addex Pharma S.A.	1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
BRPI0918055A2 (pt)	2008-09-02	2015-12-01	Addex Pharmaceuticals Sa	derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
UA105187C2 (uk) *	2008-10-02	2014-04-25	Таісо Фармас'Ютікел Ко., Лтд.	Похідне 7-піперидиналкіл-3,4-дигідрохінолону
MX2011005242A (es)	2008-11-28	2011-09-06	Ortho Mcneil Janssen Pharm	Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos.
MY161325A (en)	2009-05-12	2017-04-14	Janssen Pharmaceuticals Inc	1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
AR076859A1 (es)	2009-05-12	2011-07-13	Ortho Mcneil Janssen Pharm	Derivados de 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2 , composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos.
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2552879T3 (es)	2010-11-08	2015-12-02	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
ES2536433T3 (es)	2010-11-08	2015-05-25	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
WO2012062750A1 (en)	2010-11-08	2012-05-18	Janssen Pharmaceuticals, Inc.	1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20200126026A (ko)	2014-01-21	2020-11-05	얀센 파마슈티카 엔.브이.	대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
CN106061504B (zh)	2014-01-21	2019-09-06	詹森药业有限公司	包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
SG10201913587WA (en)	2016-02-05	2020-02-27	Denali Therapeutics Inc	Inhibitors of receptor-interacting protein kinase 1
EP3552017B1 (en)	2016-12-09	2022-02-23	Denali Therapeutics Inc.	Compounds useful as ripk1 inhibitors
CN108707109A (zh) *	2018-08-29	2018-10-26	常州沃腾化工科技有限公司	一种2-甲氧基-4-三氟甲基吡啶-3-磺酰氯的制备方法
AU2023206890A1 (en)	2022-01-12	2024-08-22	Denali Therapeutics Inc.	Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1278792C (en) *	1985-05-06	1991-01-08	Joseph P. Yevich	Antipsychotic fused-ring pyridinylpiperazine derivatives
KR910006138B1 (ko) *	1986-09-30	1991-08-16	에자이 가부시끼가이샤	환상아민 유도체
FR2644786B1 (fr) *	1989-03-21	1993-12-31	Adir Cie	Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
WO1997010238A1 (fr) *	1995-09-15	1997-03-20	Synthelabo	Derives de quinolein-2(1h)-one comme antagonistes de la serotonine

1996
- 1996-09-12 WO PCT/FR1996/001401 patent/WO1997010238A1/fr active IP Right Grant
- 1996-09-12 UA UA98031235A patent/UA44332C2/uk unknown
- 1996-09-12 RU RU98106501/04A patent/RU2167874C2/ru not_active IP Right Cessation
- 1996-09-12 HU HU9802940A patent/HU222745B1/hu not_active IP Right Cessation
- 1996-09-12 CA CA002228038A patent/CA2228038C/en not_active Expired - Fee Related
- 1996-09-12 KR KR10-1998-0701920A patent/KR100422850B1/ko not_active IP Right Cessation
- 1996-09-12 US US09/011,482 patent/US5958924A/en not_active Expired - Lifetime
- 1996-09-12 JP JP51170797A patent/JP3335362B2/ja not_active Expired - Fee Related
- 1996-09-12 CZ CZ1998786A patent/CZ288149B6/cs not_active IP Right Cessation
- 1996-09-12 EE EE9800089A patent/EE04116B1/xx not_active IP Right Cessation
- 1996-09-12 TR TR1998/00464T patent/TR199800464T1/xx unknown
- 1996-09-12 EP EP96931112A patent/EP0850235B1/fr not_active Expired - Lifetime
- 1996-09-12 SK SK346-98A patent/SK282222B6/sk not_active IP Right Cessation
- 1996-09-12 DK DK96931112T patent/DK0850235T3/da active
- 1996-09-12 CN CN96198333A patent/CN1094490C/zh not_active Expired - Fee Related
- 1996-09-12 AR ARP960104322A patent/AR003996A1/es active IP Right Grant
- 1996-09-12 CO CO96048698A patent/CO4750663A1/es unknown
- 1996-09-12 BR BR9610579A patent/BR9610579A/pt not_active Application Discontinuation
- 1996-09-12 ES ES96931112T patent/ES2142089T3/es not_active Expired - Lifetime
- 1996-09-12 SI SI9630151T patent/SI0850235T1/xx unknown
- 1996-09-12 AT AT96931112T patent/ATE187172T1/de active
- 1996-09-12 PL PL96325467A patent/PL184808B1/pl not_active IP Right Cessation
- 1996-09-12 NZ NZ318436A patent/NZ318436A/xx not_active IP Right Cessation
- 1996-09-12 AU AU69919/96A patent/AU715879B2/en not_active Ceased
- 1996-09-12 IL IL12360096A patent/IL123600A/en not_active IP Right Cessation
- 1996-09-12 DE DE69605430T patent/DE69605430T2/de not_active Expired - Lifetime
1998
- 1998-03-11 BG BG102316A patent/BG63779B1/bg unknown
- 1998-03-13 NO NO19981141A patent/NO323841B1/no not_active IP Right Cessation
- 1998-12-30 HK HK98119241A patent/HK1014868A1/xx not_active IP Right Cessation
2000
- 2000-02-09 GR GR20000400317T patent/GR3032618T3/el unknown

Also Published As

Publication number	Publication date
EE9800089A (et)	1998-10-15
SI0850235T1 (en)	2000-04-30
DE69605430D1 (de)	2000-01-05
NO981141L (no)	1998-05-15
TR199800464T1 (xx)	1998-05-21
AR003996A1 (es)	1998-09-30
CO4750663A1 (es)	1999-03-31
BG102316A (bg)	1999-03-31
HK1014868A1 (en)	1999-10-08
JPH11514982A (ja)	1999-12-21
CN1202168A (zh)	1998-12-16
GR3032618T3 (en)	2000-05-31
SK34698A3 (en)	1998-08-05
NO323841B1 (no)	2007-07-09
JP3335362B2 (ja)	2002-10-15
NO981141D0 (no)	1998-03-13
UA44332C2 (uk)	2002-02-15
HU222745B1 (hu)	2003-09-29
PL184808B1 (pl)	2002-12-31
SK282222B6 (sk)	2001-12-03
MX9802028A (es)	1998-09-30
EP0850235A1 (fr)	1998-07-01
IL123600A (en)	2001-05-20
CA2228038A1 (en)	1997-03-20
AU6991996A (en)	1997-04-01
EP0850235B1 (fr)	1999-12-01
ES2142089T3 (es)	2000-04-01
AU715879B2 (en)	2000-02-10
RU2167874C2 (ru)	2001-05-27
BR9610579A (pt)	1999-07-06
WO1997010238A1 (fr)	1997-03-20
CZ288149B6 (en)	2001-05-16
ATE187172T1 (de)	1999-12-15
EE04116B1 (et)	2003-08-15
NZ318436A (en)	1999-02-25
IL123600A0 (en)	1998-10-30
KR100422850B1 (ko)	2004-07-23
DE69605430T2 (de)	2000-07-13
CN1094490C (zh)	2002-11-20
CZ78698A3 (cs)	1998-06-17
PL325467A1 (en)	1998-07-20
US5958924A (en)	1999-09-28
HUP9802940A2 (hu)	1999-05-28
HUP9802940A3 (en)	2001-11-28
BG63779B1 (bg)	2002-12-29
KR19990044666A (ko)	1999-06-25
CA2228038C (en)	2009-04-21

Publication	Publication Date	Title
DK0850235T3 (da)	2000-05-29	Derivater af quinolin-2(1H)-on som serotoninantagonister
NO965036D0 (no)	1996-11-26	Kinolinderivater som techykinin NK3 reseptor-antagonister
IS5041A (is)	1999-04-30	Sambræddar bísýklískar pýrimidín afleiður
NO20010684L (no)	2001-04-09	Substituert 1,8-naftyridin-4(1H)-on som fosfodiesterase 4 inhibitorer
NO20001962D0 (no)	2000-04-14	Terapeutisk anvendelse av kinolinderivater
DK0839136T3 (da)	2001-08-06	Benzo[g]quinolinderivater
DK0922034T3 (da)	2002-11-18	Tetrahydroquinolinderivater som EAA-antagonister
NO982332D0 (no)	1998-05-22	Salter av kinolin-derivater som NK3 antagonister
NO983333D0 (no)	1998-07-17	Kinolin-2-(1H)-on
AU6923998A (en)	1998-10-20	Quinoline-2(1h)-one and dihydroquinoline-2(1h)-one derivatives as ligands of 5-ht, 5-ht2 and 5-ht1-like receptors
ATE281436T1 (de)	2004-11-15	Chinolin-4-yl-derivate
NO20013407D0 (no)	2001-07-10	Fremgangsmåte for fremstilling av kinolinkarbaldehyd
EE04372B1 (et)	2004-10-15	5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid
DK0912553T3 (da)	2002-04-22	Benzo[g]quinolin-derivater
FI970143A0 (fi)	1997-01-14	Kinoliinijohdannaiset leukotrieeniantagonisteina
HU9900343D0 (en)	1999-04-28	Use of quinoline derivatives having tachycinin nk3 receptor antagonist
DK0940391T3 (da)	2004-12-06	Quinolinderivater som tachykinin-NK3-receptor-antagonister